Delivery Order SPE2DB22D3501-SPE2DB25FVH60
Award Date
4/17/25
Potential Completion Date
4/18/25
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,916.00, is for the delivery of 4,567,956,738 units of the pharmaceutical product Renflexis 100 mg vials. The contract has an ultimate completion date of April 18, 2025 and was awarded on April 17, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Renflexis 100 mg vials. The contract is a firm fixed-price delivery order with a ceiling value of $8,516.00 and a period of performance through April 30, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $10,907.52, is for the supply of the pharmaceutical product Renflexis 100 mg vials. The ultimate completion date is July 22, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Renflexis 100 mg vials. The contract has a ceiling value of $1,242.50 and runs through December 12, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,093.08, is for the delivery of Renflexis 100 mg vials. It is a firm fixed-price contract with an ultimate completion date of April 16, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Renflexis 100 mg vials. The contract has a ceiling value of $4,069.16 and a period of performance ending on November 4, 2024. The contract was awarded on November 1, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 100 mg vials of the drug Renflexis. The contract has a firm fixed price of $2,982.00 and a completion date of May 20, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical. The IDC allows AmerisourceBergen to supply a wide range...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,040.98, is for the delivery of Renflexis 100 mg vials, a pharmaceutical product. The contract is a firm fixed-price delivery order with a performance period ending on May 2, 2025. This contract is not associated with a set-aside and appears to be an open competition award....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4557385111 Renflexis 100 mg vials. The single-award Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, serves as the primary vehicle for DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Renflexis 100 mg vials. The contract has a ceiling value of $27,832.00 and a completion date of February 10, 2025. It is a firm-fixed-price contract type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves...